You have 9 free searches left this month | to do more
Showing 1 - 25 of
688 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Withdrawn
  • SCLC
  • NSCLC
  • MILs™ in Combination with Pembrolizumab
  • (no location specified)
2021-10-01
Oct 1, 2021
I
Not yet recruiting
  • Small-cell Lung Cancer
  • Paris, France
  • +1 more
2022-03-16
Mar 16, 2022
I
Recruiting
  • Small Cell Lung Cancer
  • atezolizumab
  • Chalon-sur-Saône, France
  • +1 more
2022-03-04
Mar 4, 2022
F
Not yet recruiting
  • Small-cell Lung Cancer
    • (no location specified)
    2021-03-08
    Mar 8, 2021
    C
    Recruiting
    • Small Cell Lung Cancer SCLC
    • München Gauting, Germany
      Klinik München Gauting
    2021-01-26
    Jan 26, 2021
    J
    Recruiting
    • SCLC
    • Brain Metastases
    • SRS
    • WBRT
    • Heidelberg, Germany
      University Hospital of Heidelberg, Department of Radiation Oncol
    2021-09-28
    Sep 28, 2021
    F
    Recruiting
    • Small Cell Lung Cancer
    • Blood sample collection
    • Shanghai, Shanghai, China
      Cancer hospital Fudan University
    2022-01-10
    Jan 10, 2022
    J
    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    2021-12-14
    Dec 14, 2021
    X
    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Observation
    • (no location specified)
    2021-09-22
    Sep 22, 2021
    C
    Recruiting
    • Relapsed Small Cell Lung Cancer
    • Chendu, Sichuan, China
      West China Hospital, Sichuan University
    2022-02-17
    Feb 17, 2022
    N
    Recruiting
    • Small Cell Lung Cancer Recurrent
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    2022-04-04
    Apr 4, 2022
    C
    Recruiting
    • Small-cell Lung Cancer
    • Cleveland, Ohio
      Case Medical Center, University Hospitals Seidman Cancer Center,
    2022-03-14
    Mar 14, 2022
    H
    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • Anlotinib Tislelizumab Irinotecan
    • Guangzhou, Guangdong, China
      Guangdong Provincial Hospital of Traditional Chinese Medicine
    2021-11-22
    Nov 22, 2021
    H
    Recruiting
    • Small Cell Lung Carcinoma
    • Camrelizumab Plus Apatinib
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    2021-11-24
    Nov 24, 2021
    Z
    Recruiting
    • Small Cell Lung Cancer Limited Stage
    • Hyperfractionated radiotherapy
    • +3 more
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    2020-09-02
    Sep 2, 2020
    N
    Recruiting
    • SCLC
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    A
    Suspended
    • Small Cell Lung Cancer
    • AMG 119
    • Tampa, Florida
    • +1 more
    2021-11-29
    Nov 29, 2021
    I
    Recruiting
    • SCLC
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    2021-09-14
    Sep 14, 2021
    H
    Recruiting
    • Small-cell Lung Cancer
    • +2 more
    • Kissimmee, Florida
    • +1 more
    2022-01-27
    Jan 27, 2022
    S
    Completed
    • SCLC
    • Seoul, Korea, Republic of
      Samsung Medical Center
    2019-12-05
    Dec 5, 2019
    S
    Completed
    • Small-cell Lung Cancer
    • +2 more
    • Hippocampal-sparing Prophylactic Cranial Irradiation
    • Baltimore, Maryland
    • +1 more
    2021-09-22
    Sep 22, 2021
    A
    Terminated
    • Small Cell Lung Cancer and Other Solid Tumors
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    2021-08-24
    Aug 24, 2021
    V
    Withdrawn
    • Relapsed Small Cell Lung Cancer
    • Refractory Small Cell Lung Carcinoma
    • Venetoclax 50 MG
    • +6 more
    • (no location specified)
    2021-03-01
    Mar 1, 2021